NDC 0023-6118

Condylox

Podofilox

Condylox is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Podofilox.

Product ID0023-6118_01b8d25b-e7d0-43eb-b24e-6ef9a9a8072a
NDC0023-6118
Product TypeHuman Prescription Drug
Proprietary NameCondylox
Generic NamePodofilox
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date1997-03-13
Marketing CategoryNDA / NDA
Application NumberNDA020529
Labeler NameAllergan, Inc.
Substance NamePODOFILOX
Active Ingredient Strength5 mg/g
Pharm ClassesDecreased Mitosis [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0023-6118-03

3.5 g in 1 TUBE, WITH APPLICATOR (0023-6118-03)
Marketing Start Date1997-03-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0023-6118-03 [00023611803]

Condylox GEL
Marketing CategoryNDA
Application NumberNDA020529
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date1997-03-13

Drug Details

Active Ingredients

IngredientStrength
PODOFILOX5 mg/g

OpenFDA Data

SPL SET ID:032e4bcb-b1ed-4029-b2a6-e92f3bf5cc37
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312466
  • 351750
  • Pharmacological Class

    • Decreased Mitosis [PE]

    NDC Crossover Matching brand name "Condylox" or generic name "Podofilox"

    NDCBrand NameGeneric Name
    0023-6118Condyloxpodofilox
    0574-0611PODOFILOXPODOFILOX
    0591-3204PodofiloxPodofilox
    63629-8832PodofiloxPodofilox

    Trademark Results [Condylox]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CONDYLOX
    CONDYLOX
    73600709 1418919 Live/Registered
    OCLASSEN PHARMACEUTICALS, INC.
    1986-05-27

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.